New hope for depression when standard meds Aren't enough
NCT ID NCT06911112
Summary
This study is testing whether adding an investigational drug called NBI-1065845 to a person's current antidepressant medication helps reduce depression symptoms more effectively. It's for adults with moderate-to-severe major depression who haven't gotten enough relief from their current antidepressant treatment alone. Participants will continue taking their regular antidepressant and will be randomly assigned to also receive either the study drug or a placebo for 8 weeks to compare results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Neurocrine Clinical Site
RECRUITINGHuntsville, Alabama, 35801, United States
-
Neurocrine Clinical Site
RECRUITINGGlendale, California, 91206, United States
-
Neurocrine Clinical Site
RECRUITINGIrvine, California, 92614, United States
-
Neurocrine Clinical Site
RECRUITINGMiami, Florida, 33174, United States
-
Neurocrine Clinical Site
RECRUITINGTampa, Florida, 33607, United States
-
Neurocrine Clinical Site
RECRUITINGAtlanta, Georgia, 30318, United States
-
Neurocrine Clinical Site
RECRUITINGBoston, Massachusetts, 02131, United States
-
Neurocrine Clinical Site
RECRUITINGSaint Charles, Missouri, 63304, United States
-
Neurocrine Clinical Site
RECRUITINGThe Bronx, New York, 10461, United States
-
Neurocrine Clinical Site
RECRUITINGMason, Ohio, 45040, United States
Conditions
Explore the condition pages connected to this study.